Microsoft To Rally Around 6%? Here Are 10 Top Analyst Forecasts For Tuesday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts have updated their outlooks on several major stocks, including Microsoft, Revolution Medicines, Goldman Sachs, BlackRock, Starbucks, S&P Global, Profound Medical, Dollar Tree, Shopify, and Atlassian. These updates include both price target changes and rating adjustments.
July 16, 2024 | 12:05 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Piper Sandler cut Dollar Tree's price target from $143 to $112 and downgraded the stock from Overweight to Neutral. Shares fell 3.3% to close at $103.83.
The price target cut and downgrade indicate negative sentiment, likely leading to further short-term declines.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Evercore ISI Group cut the price target for Starbucks from $92 to $80 and downgraded the stock from Outperform to In-Line. Shares fell 2.8% to close at $72.75.
The price target cut and downgrade indicate negative sentiment, likely leading to further short-term declines.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
NEUTRAL IMPACT
Keefe, Bruyette & Woods increased BlackRock's price target from $915 to $934, maintaining an Outperform rating. Shares fell 0.6% to close at $822.96.
Despite the price target increase and maintained Outperform rating, the stock fell, indicating mixed short-term sentiment.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEUTRAL IMPACT
Mizuho slashed Atlassian's price target from $225 to $220, maintaining an Outperform rating. Shares fell 0.8% to close at $179.95.
The slight price target cut and maintained Outperform rating suggest mixed sentiment, likely leading to neutral short-term impact.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Morgan Stanley increased the price target for Goldman Sachs from $475 to $513, maintaining an Overweight rating. Shares gained 2.6% to close at $492.23.
The price target increase and maintained Overweight rating from Morgan Stanley suggest strong positive sentiment, likely boosting short-term investor confidence.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Mizuho raised the price target for Microsoft from $450 to $480, maintaining an Outperform rating. Shares gained 0.1% to close at $453.96.
The price target increase and maintained Outperform rating from Mizuho suggest positive sentiment, likely boosting short-term investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Stifel raised Profound Medical's price target from $9 to $12 and upgraded the stock from Hold to Buy. Shares fell 1.3% to close at $9.15.
The price target increase and upgrade to Buy indicate positive sentiment, though the stock's decline suggests mixed short-term reactions.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
HC Wainwright & Co. boosted the price target for Revolution Medicines from $44 to $56, maintaining a Buy rating. Shares gained 1.9% to close at $46.00.
The significant price target increase and maintained Buy rating indicate strong positive sentiment, likely driving short-term gains.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
B of A Securities boosted Shopify's price target from $78 to $82 and upgraded the stock from Neutral to Buy. Shares fell 1.1% to close at $64.21.
The price target increase and upgrade to Buy indicate positive sentiment, though the stock's decline suggests mixed short-term reactions.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
B of A Securities raised S&P Global's price target from $530 to $540, maintaining a Buy rating. Shares gained 0.9% to close at $482.55.
The price target increase and maintained Buy rating suggest positive sentiment, likely boosting short-term investor confidence.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100